Remedium Lifecare Ltd. (BSE: REMLIFE.BO) Stock Competitors & Peer Comparison
See REMLIFE.BO's competitors and their performance on the BSE and across the wider stock market.
Peer Comparison Table: Auto - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for REMLIFE.BO and its BSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| REMLIFE.BO | ₹0.85 | +0.00% | 749.7M | 6.54 | ₹0.13 | N/A |
| MARUTI.BO | ₹13,457.50 | +0.46% | 4.2T | 29.05 | ₹463.21 | +1.00% |
| MARUTI.NS | ₹13,442.00 | +0.29% | 4.2T | 30.00 | ₹448.04 | +1.00% |
| TATAMTRDVR.BO | ₹765.15 | +2.53% | 3.9T | 8.69 | ₹88.07 | +0.93% |
| M&M.NS | ₹3,161.40 | -2.11% | 3.8T | 24.18 | ₹130.76 | +1.04% |
| TATAMTRDVR.NS | ₹760.00 | -1.13% | 3.7T | 8.64 | ₹88.01 | N/A |
| BAJAJ-AUTO.BO | ₹11,128.05 | -1.34% | 3.1T | 32.41 | ₹343.30 | +1.35% |
| BAJAJ-AUTO.NS | ₹11,130.00 | -1.36% | 3.1T | 31.18 | ₹356.98 | +1.35% |
| EICHERMOT.BO | ₹7,628.40 | -1.18% | 2.1T | 37.63 | ₹202.70 | +0.92% |
| EICHERMOT.NS | ₹7,628.00 | -1.21% | 2.1T | 37.40 | ₹203.96 | +0.92% |
Stock Comparison
Maruti Suzuki India Limited (BSE: MARUTI.BO)
REMLIFE.BO vs MARUTI.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, MARUTI.BO has a market cap of 4.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while MARUTI.BO trades at ₹13,457.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas MARUTI.BO's P/E ratio is 29.05. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to MARUTI.BO's ROE of +0.15%. Regarding short-term risk, REMLIFE.BO is more volatile compared to MARUTI.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check MARUTI.BO's competition here
Maruti Suzuki India Limited (NSE: MARUTI.NS)
REMLIFE.BO vs MARUTI.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, MARUTI.NS has a market cap of 4.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while MARUTI.NS trades at ₹13,442.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas MARUTI.NS's P/E ratio is 30.00. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to MARUTI.NS's ROE of +0.15%. Regarding short-term risk, REMLIFE.BO is more volatile compared to MARUTI.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check MARUTI.NS's competition here
Tata Motors Limited (BSE: TATAMTRDVR.BO)
REMLIFE.BO vs TATAMTRDVR.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TATAMTRDVR.BO has a market cap of 3.9T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TATAMTRDVR.BO trades at ₹765.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TATAMTRDVR.BO's P/E ratio is 8.69. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TATAMTRDVR.BO's ROE of +0.70%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TATAMTRDVR.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TATAMTRDVR.BO's competition here
Mahindra & Mahindra Limited (NSE: M&M.NS)
REMLIFE.BO vs M&M.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, M&M.NS has a market cap of 3.8T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while M&M.NS trades at ₹3,161.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas M&M.NS's P/E ratio is 24.18. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to M&M.NS's ROE of +0.17%. Regarding short-term risk, REMLIFE.BO is more volatile compared to M&M.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check M&M.NS's competition here
Tata Motors Passenger Vehicles Ltd. - Ordinary Shares - DVR (Class A) (NSE: TATAMTRDVR.NS)
REMLIFE.BO vs TATAMTRDVR.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TATAMTRDVR.NS has a market cap of 3.7T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TATAMTRDVR.NS trades at ₹760.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TATAMTRDVR.NS's P/E ratio is 8.64. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TATAMTRDVR.NS's ROE of +0.28%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TATAMTRDVR.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TATAMTRDVR.NS's competition here
Bajaj Auto Limited (BSE: BAJAJ-AUTO.BO)
REMLIFE.BO vs BAJAJ-AUTO.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, BAJAJ-AUTO.BO has a market cap of 3.1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while BAJAJ-AUTO.BO trades at ₹11,128.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas BAJAJ-AUTO.BO's P/E ratio is 32.41. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to BAJAJ-AUTO.BO's ROE of +0.33%. Regarding short-term risk, REMLIFE.BO is more volatile compared to BAJAJ-AUTO.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check BAJAJ-AUTO.BO's competition here
Bajaj Auto Limited (NSE: BAJAJ-AUTO.NS)
REMLIFE.BO vs BAJAJ-AUTO.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, BAJAJ-AUTO.NS has a market cap of 3.1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while BAJAJ-AUTO.NS trades at ₹11,130.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas BAJAJ-AUTO.NS's P/E ratio is 31.18. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to BAJAJ-AUTO.NS's ROE of +0.33%. Regarding short-term risk, REMLIFE.BO is more volatile compared to BAJAJ-AUTO.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check BAJAJ-AUTO.NS's competition here
Eicher Motors Limited (BSE: EICHERMOT.BO)
REMLIFE.BO vs EICHERMOT.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, EICHERMOT.BO has a market cap of 2.1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while EICHERMOT.BO trades at ₹7,628.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas EICHERMOT.BO's P/E ratio is 37.63. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to EICHERMOT.BO's ROE of +0.24%. Regarding short-term risk, REMLIFE.BO is more volatile compared to EICHERMOT.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check EICHERMOT.BO's competition here
Eicher Motors Limited (NSE: EICHERMOT.NS)
REMLIFE.BO vs EICHERMOT.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, EICHERMOT.NS has a market cap of 2.1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while EICHERMOT.NS trades at ₹7,628.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas EICHERMOT.NS's P/E ratio is 37.40. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to EICHERMOT.NS's ROE of +0.24%. Regarding short-term risk, REMLIFE.BO is more volatile compared to EICHERMOT.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check EICHERMOT.NS's competition here
TVS Motor Company Limited (BSE: TVSMOTOR.BO)
REMLIFE.BO vs TVSMOTOR.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TVSMOTOR.BO has a market cap of 1.8T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TVSMOTOR.BO trades at ₹3,870.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TVSMOTOR.BO's P/E ratio is 54.51. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TVSMOTOR.BO's ROE of +0.38%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TVSMOTOR.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TVSMOTOR.BO's competition here
TVS Motor Company Limited (NSE: TVSMOTOR.NS)
REMLIFE.BO vs TVSMOTOR.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TVSMOTOR.NS has a market cap of 1.8T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TVSMOTOR.NS trades at ₹3,870.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TVSMOTOR.NS's P/E ratio is 50.15. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TVSMOTOR.NS's ROE of +0.38%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TVSMOTOR.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TVSMOTOR.NS's competition here
Hyundai Motor India Limited (NSE: HYUNDAI.NS)
REMLIFE.BO vs HYUNDAI.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HYUNDAI.NS has a market cap of 1.6T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HYUNDAI.NS trades at ₹1,952.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HYUNDAI.NS's P/E ratio is 29.20. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HYUNDAI.NS's ROE of +0.30%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HYUNDAI.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HYUNDAI.NS's competition here
Hyundai Motor India Limited (BSE: HYUNDAI.BO)
REMLIFE.BO vs HYUNDAI.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HYUNDAI.BO has a market cap of 1.6T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HYUNDAI.BO trades at ₹1,953.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HYUNDAI.BO's P/E ratio is 29.20. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HYUNDAI.BO's ROE of +0.30%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HYUNDAI.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HYUNDAI.BO's competition here
Tata Motors Ltd. (NSE: TMCV.NS)
REMLIFE.BO vs TMCV.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TMCV.NS has a market cap of 1.5T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TMCV.NS trades at ₹406.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TMCV.NS's P/E ratio is 26.56. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TMCV.NS's ROE of +0.08%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TMCV.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TMCV.NS's competition here
Tata Motors Limited (BSE: TMCV.BO)
REMLIFE.BO vs TMCV.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TMCV.BO has a market cap of 1.5T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TMCV.BO trades at ₹406.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TMCV.BO's P/E ratio is 35.02. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TMCV.BO's ROE of +0.08%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TMCV.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TMCV.BO's competition here
Tata Motors Ltd. (BSE: TATAMOTORS.BO)
REMLIFE.BO vs TATAMOTORS.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TATAMOTORS.BO has a market cap of 1.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TATAMOTORS.BO trades at ₹323.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TATAMOTORS.BO's P/E ratio is 5.33. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TATAMOTORS.BO's ROE of +0.70%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TATAMOTORS.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TATAMOTORS.BO's competition here
Tata Motors Limited (NSE: TATAMOTORS.NS)
REMLIFE.BO vs TATAMOTORS.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TATAMOTORS.NS has a market cap of 1.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TATAMOTORS.NS trades at ₹323.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TATAMOTORS.NS's P/E ratio is 5.32. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TATAMOTORS.NS's ROE of +0.70%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TATAMOTORS.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TATAMOTORS.NS's competition here
Tata Motors Passenger Vehicles (BSE: TMPV.BO)
REMLIFE.BO vs TMPV.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TMPV.BO has a market cap of 1.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TMPV.BO trades at ₹323.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TMPV.BO's P/E ratio is -45.81. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TMPV.BO's ROE of +0.70%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TMPV.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TMPV.BO's competition here
Tata Motors Passenger Vehicles Limited (NSE: TMPV.NS)
REMLIFE.BO vs TMPV.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TMPV.NS has a market cap of 1.2T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TMPV.NS trades at ₹323.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TMPV.NS's P/E ratio is -46.11. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TMPV.NS's ROE of +0.70%. Regarding short-term risk, REMLIFE.BO is more volatile compared to TMPV.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TMPV.NS's competition here
Hero MotoCorp Limited (BSE: HEROMOTOCO.BO)
REMLIFE.BO vs HEROMOTOCO.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HEROMOTOCO.BO has a market cap of 1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HEROMOTOCO.BO trades at ₹5,010.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HEROMOTOCO.BO's P/E ratio is 17.41. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HEROMOTOCO.BO's ROE of +0.28%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HEROMOTOCO.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HEROMOTOCO.BO's competition here
Hero MotoCorp Limited (NSE: HEROMOTOCO.NS)
REMLIFE.BO vs HEROMOTOCO.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HEROMOTOCO.NS has a market cap of 1T. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HEROMOTOCO.NS trades at ₹5,011.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HEROMOTOCO.NS's P/E ratio is 17.17. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HEROMOTOCO.NS's ROE of +0.28%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HEROMOTOCO.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HEROMOTOCO.NS's competition here
Ather Energy Ltd. (NSE: ATHERENERG.NS)
REMLIFE.BO vs ATHERENERG.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, ATHERENERG.NS has a market cap of 463.3B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while ATHERENERG.NS trades at ₹1,208.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas ATHERENERG.NS's P/E ratio is -251.81. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to ATHERENERG.NS's ROE of -0.24%. Regarding short-term risk, REMLIFE.BO is more volatile compared to ATHERENERG.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check ATHERENERG.NS's competition here
Force Motors Limited (NSE: FORCEMOT.NS)
REMLIFE.BO vs FORCEMOT.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, FORCEMOT.NS has a market cap of 232.2B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while FORCEMOT.NS trades at ₹17,620.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas FORCEMOT.NS's P/E ratio is 15.79. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to FORCEMOT.NS's ROE of +0.34%. Regarding short-term risk, REMLIFE.BO is more volatile compared to FORCEMOT.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check FORCEMOT.NS's competition here
Force Motors Limited (BSE: FORCEMOT.BO)
REMLIFE.BO vs FORCEMOT.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, FORCEMOT.BO has a market cap of 232.2B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while FORCEMOT.BO trades at ₹17,627.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas FORCEMOT.BO's P/E ratio is 19.17. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to FORCEMOT.BO's ROE of +0.34%. Regarding short-term risk, REMLIFE.BO is more volatile compared to FORCEMOT.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check FORCEMOT.BO's competition here
Ola Electric Mobility Limited (NSE: OLAELEC.NS)
REMLIFE.BO vs OLAELEC.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, OLAELEC.NS has a market cap of 163.8B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while OLAELEC.NS trades at ₹37.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas OLAELEC.NS's P/E ratio is -8.28. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to OLAELEC.NS's ROE of -0.43%. Regarding short-term risk, REMLIFE.BO is more volatile compared to OLAELEC.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check OLAELEC.NS's competition here
Olectra Greentech Limited (NSE: OLECTRA.NS)
REMLIFE.BO vs OLECTRA.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, OLECTRA.NS has a market cap of 109.7B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while OLECTRA.NS trades at ₹1,336.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas OLECTRA.NS's P/E ratio is 73.99. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to OLECTRA.NS's ROE of +0.16%. Regarding short-term risk, REMLIFE.BO is more volatile compared to OLECTRA.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check OLECTRA.NS's competition here
Olectra Greentech Limited (BSE: OLECTRA.BO)
REMLIFE.BO vs OLECTRA.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, OLECTRA.BO has a market cap of 109.5B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while OLECTRA.BO trades at ₹1,334.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas OLECTRA.BO's P/E ratio is 76.59. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to OLECTRA.BO's ROE of +0.16%. Regarding short-term risk, REMLIFE.BO is more volatile compared to OLECTRA.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check OLECTRA.BO's competition here
SML Mahindra Limited (NSE: SMLISUZU.NS)
REMLIFE.BO vs SMLISUZU.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, SMLISUZU.NS has a market cap of 62.5B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while SMLISUZU.NS trades at ₹4,319.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas SMLISUZU.NS's P/E ratio is 44.22. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to SMLISUZU.NS's ROE of +0.37%. Regarding short-term risk, REMLIFE.BO is less volatile compared to SMLISUZU.NS. This indicates lower risk in terms of short-term price fluctuations for REMLIFE.BO.Check SMLISUZU.NS's competition here
SML Mahindra Limited (BSE: SMLISUZU.BO)
REMLIFE.BO vs SMLISUZU.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, SMLISUZU.BO has a market cap of 55.6B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while SMLISUZU.BO trades at ₹3,845.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas SMLISUZU.BO's P/E ratio is 39.34. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to SMLISUZU.BO's ROE of +0.37%. Regarding short-term risk, REMLIFE.BO is more volatile compared to SMLISUZU.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check SMLISUZU.BO's competition here
SML Mahindra Limited (BSE: SMLMAH.BO)
REMLIFE.BO vs SMLMAH.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, SMLMAH.BO has a market cap of 55.6B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while SMLMAH.BO trades at ₹3,845.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas SMLMAH.BO's P/E ratio is 317.53. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to SMLMAH.BO's ROE of +0.35%. Regarding short-term risk, REMLIFE.BO is more volatile compared to SMLMAH.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check SMLMAH.BO's competition here
Sml Mahindra Ltd. (NSE: SMLMAH.NS)
REMLIFE.BO vs SMLMAH.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, SMLMAH.NS has a market cap of 55.6B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while SMLMAH.NS trades at ₹3,844.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas SMLMAH.NS's P/E ratio is 317.46. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to SMLMAH.NS's ROE of +0.35%. Regarding short-term risk, REMLIFE.BO is more volatile compared to SMLMAH.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check SMLMAH.NS's competition here
Atul Auto Limited (BSE: ATULAUTO.BO)
REMLIFE.BO vs ATULAUTO.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, ATULAUTO.BO has a market cap of 13.2B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while ATULAUTO.BO trades at ₹474.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas ATULAUTO.BO's P/E ratio is 35.43. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to ATULAUTO.BO's ROE of +0.09%. Regarding short-term risk, REMLIFE.BO is more volatile compared to ATULAUTO.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check ATULAUTO.BO's competition here
Atul Auto Limited (NSE: ATULAUTO.NS)
REMLIFE.BO vs ATULAUTO.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, ATULAUTO.NS has a market cap of 13.1B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while ATULAUTO.NS trades at ₹473.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas ATULAUTO.NS's P/E ratio is 37.96. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to ATULAUTO.NS's ROE of +0.09%. Regarding short-term risk, REMLIFE.BO is more volatile compared to ATULAUTO.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check ATULAUTO.NS's competition here
Scooters India Limited (BSE: SCOOTER.BO)
REMLIFE.BO vs SCOOTER.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, SCOOTER.BO has a market cap of 6.9B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while SCOOTER.BO trades at ₹78.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas SCOOTER.BO's P/E ratio is -45.84. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to SCOOTER.BO's ROE of -0.11%. Regarding short-term risk, REMLIFE.BO is more volatile compared to SCOOTER.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check SCOOTER.BO's competition here
Hindustan Motors Limited (NSE: HINDMOTORS.NS)
REMLIFE.BO vs HINDMOTORS.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HINDMOTORS.NS has a market cap of 3.7B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HINDMOTORS.NS trades at ₹17.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HINDMOTORS.NS's P/E ratio is 3293.23. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HINDMOTORS.NS's ROE of -0.00%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HINDMOTORS.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HINDMOTORS.NS's competition here
Hindustan Motors Limited (BSE: HINDMOTORS.BO)
REMLIFE.BO vs HINDMOTORS.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, HINDMOTORS.BO has a market cap of 3.5B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while HINDMOTORS.BO trades at ₹15.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas HINDMOTORS.BO's P/E ratio is 2918.87. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to HINDMOTORS.BO's ROE of -0.00%. Regarding short-term risk, REMLIFE.BO is more volatile compared to HINDMOTORS.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check HINDMOTORS.BO's competition here
Wardwizard Innovations & Mobility Ltd. (BSE: WARDINMOBI.BO)
REMLIFE.BO vs WARDINMOBI.BO Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, WARDINMOBI.BO has a market cap of 1.7B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while WARDINMOBI.BO trades at ₹6.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas WARDINMOBI.BO's P/E ratio is 29.44. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to WARDINMOBI.BO's ROE of +0.02%. Regarding short-term risk, REMLIFE.BO is more volatile compared to WARDINMOBI.BO. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check WARDINMOBI.BO's competition here
Tunwal E-Motors Ltd. (NSE: TUNWAL.NS)
REMLIFE.BO vs TUNWAL.NS Comparison July 2026
Remedium Lifecare Ltd. (BSE: REMLIFE.BO) plays a significant role within the Consumer Cyclical sector. Its performance on the BSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, REMLIFE.BO stands at 749.7M. In comparison, TUNWAL.NS has a market cap of 1.5B. Regarding current trading prices, REMLIFE.BO is priced at ₹0.85 on the BSE, while TUNWAL.NS trades at ₹26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
REMLIFE.BO currently has a P/E ratio of 6.54, whereas TUNWAL.NS's P/E ratio is 11.47. In terms of profitability, REMLIFE.BO's ROE is +0.17%, compared to TUNWAL.NS's ROE of N/A. Regarding short-term risk, REMLIFE.BO is more volatile compared to TUNWAL.NS. This indicates higher risk in terms of short-term price fluctuations for REMLIFE.BO.Check TUNWAL.NS's competition here